Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unresectable Hepatocellular Carcinoma × Bumetanide × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Unresectable Hepatocellular Carcinoma 1

Interventions

tremelimumab 1 durvalumab 1 atezolizumab 1 Therapeutics 1 Immunotherapy 1 Bumetanide 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03107416 2025-05-01

Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells

Memorial Sloan Kettering Cancer Center

Phase 1/2 Active not recruiting

Gastrointestinal

Unresectable Hepatocellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡